https://nascsa.org/deas-annual-threat-assessment-spotlights-electronic-prescribing-fraud-and-use-of-counterfeit-pills/ 2024-09-09T17:27:37+00:00 https://nascsa.org/wp-content/uploads/2024/07/Pill-header.jpg https://nascsa.org/lappa-publishes-report-on-status-of-state-laws-for-regulating-kratom/ 2024-09-09T17:29:25+00:00 https://nascsa.org/wp-content/uploads/2024/07/Pill-header.jpg https://nascsa.org/save-the-date-for-nascsas-40th-annual-conference/ 2024-09-09T17:33:56+00:00 https://nascsa.org/wp-content/uploads/2024/07/Pill-header.jpg https://nascsa.org/dea-encourages-communities-to-go-red-for-red-ribbon-week/ 2024-10-24T19:56:29+00:00 https://nascsa.org/nascsa-responds-to-ncpdp-white-paper/ 2024-10-24T20:01:07+00:00 https://nascsa.org/wp-content/uploads/2024/07/Pill-header.jpg https://nascsa.org/deatohostsessionontabletingandencapsulatingmachines/ 2024-10-24T20:01:16+00:00 https://nascsa.org/wp-content/uploads/2024/07/Pill-header.jpg https://nascsa.org/fda-issues-warning-letter-for-illegal-selling-cbd-products/ 2024-10-24T20:02:43+00:00 https://nascsa.org/safety-alert-video-aims-to-keep-pharmacies-safe-educate-communities/ 2024-10-24T20:05:01+00:00 https://nascsa.org/dea-to-announce-hearing-on-proposed-marijuana-rescheduling/ 2024-10-24T20:09:31+00:00 https://nascsa.org/samhsa-releases-2023-national-survey-on-drug-use-and-health/ 2024-10-24T20:13:32+00:00 https://nascsa.org/dea-publishes-guidance-for-pharmacies-dispensing-cs-during-a-cyberattack/ 2024-10-24T20:17:20+00:00 https://nascsa.org/nih-funded-study-show-most-americans-dont-know-primary-care-physicians-can-prescribe-addiction-treatment/ 2024-10-24T20:18:48+00:00 https://nascsa.org/free-ce-available-on-improving-pmp-data-integrity-available-for-pharmacists-and-technicians/ 2024-11-07T14:40:37+00:00 https://nascsa.org/enhanced-controlled-substance-ordering-system-to-launch-december-9-2024/ 2024-12-19T16:42:08+00:00 https://nascsa.org/dea-warns-of-electronic-prescription-fraud/ 2024-12-19T16:42:13+00:00 https://nascsa.org/fda-will-focus-on-transmucosal-buprenorphine-products-in-december-webinar/ 2024-12-19T16:42:18+00:00 https://nascsa.org/dea-extends-telemedicine-flexibilities-through-2025/ 2024-12-19T16:42:23+00:00 https://nascsa.org/pending-dea-extension-on-prescription-of-controlled-substances-via-telemedicine/ 2024-12-19T16:42:29+00:00 https://nascsa.org/fda-delays-enforcement-of-dscsa-compliance-deadline-with-stipulations/ 2024-12-19T16:42:35+00:00 https://nascsa.org/alaska-creates-task-force-for-the-regulation-of-fda-approved-psychedelic-medicines/ 2024-12-19T16:42:39+00:00 https://nascsa.org/national-prescription-drug-take-back-day-announced/ 2024-12-19T16:42:45+00:00 https://nascsa.org/dea-warns-drug-companies-of-cyber-attacks-that-could-lead-to-data-breaches/ 2024-12-19T16:42:51+00:00 https://nascsa.org/dea-issues-temporary-scheduling-order-for-two-synthetic-benzimidazole-opioid-substances/ 2024-12-19T16:42:56+00:00 https://nascsa.org/new-dawn-report-released-2023-data-on-substance-related-emergency-dept-visits/ 2024-12-19T19:17:50+00:00 https://nascsa.org/update-on-hhs-onc-hti-2-proposed-rules/ 2024-12-23T17:23:45+00:00 https://nascsa.org/dawn-2023-national-estimates-from-drug-related-emergency-department-visits-now-available/ 2024-12-23T17:24:53+00:00 https://nascsa.org/dea-issues-2024-edition-of-drugs-of-abuse-a-resource-guide/ 2025-01-04T14:08:15+00:00 https://nascsa.org/dea-announces-three-new-telemedicine-rules-that-continue-to-open-access-to-telehealth-treatment-while-protecting-patients/ 2025-01-16T23:38:16+00:00 https://nascsa.org/fy25-harold-rogers-prescription-drug-monitoring-program-training-and-technical-assistance-program-announced/ 2025-01-20T15:24:53+00:00 https://nascsa.org/acting-administrator-of-the-drug-enforcement-administration-named/ 2025-01-22T21:05:43+00:00 https://nascsa.org/announcing-availability-of-travel-scholarships-to-attend-nascsas-2025-annual-conference/ 2025-03-14T12:08:45+00:00 https://nascsa.org/terry-cole-nominated-to-key-post-at-the-drug-enforcement-administration/ 2025-03-14T17:07:29+00:00 https://nascsa.org/new-psm-report-uncovers-over-100-illegal-shipments-of-weight-loss-drugs-entering-us/ 2025-03-31T17:14:45+00:00 https://nascsa.org/florida-man-sentenced-to-2-5-years-for-e-prescribing-fraud/ 2025-04-22T17:30:02+00:00 https://nascsa.org/california-couple-sentenced-to-prison-for-mail-order-drug-trafficking/ 2025-04-22T17:33:23+00:00 https://nascsa.org/fda-issues-warning-on-counterfeit-ozempic/ 2025-04-22T17:34:43+00:00 https://nascsa.org/walgreens-agrees-to-pay-up-to-350m-for-illegally-filling-unlawful-opioid-prescriptions-and-for-submitting-false-claims-to-the-federal-government/ 2025-04-23T17:38:37+00:00 https://nascsa.org/trump-administration-drug-policy-focuses-on-treatment-and-overdose-reduction/ 2025-04-24T12:10:33+00:00 https://nascsa.org/dea-diversion-control-website-experiencing-outages-today-see-notice-below/ 2025-04-30T11:08:15+00:00 https://nascsa.org/recent-webinars-hosted-by-nascsa-have-been-posted/ 2025-04-30T11:28:31+00:00 https://nascsa.org/dea-statement-on-recent-service-disruption-april-24-29-2025/ 2025-05-04T13:58:44+00:00 https://nascsa.org/dea-safely-disposes-of-620000-pounds-of-unused-medications-on-28th-national-prescription-drug-take-back-day/ 2025-05-08T17:51:10+00:00 https://nascsa.org/nascsa-to-participate-at-nabp-national-meeting/ 2025-05-08T18:01:33+00:00 https://nascsa.org/dea-takes-action-against-pharmacy-that-could-not-account-for-close-to-50k-pills/ 2025-05-09T17:50:32+00:00 https://nascsa.org/nascsas-2025-annual-conference-preliminary-agenda-posted/ 2025-05-15T13:31:30+00:00 https://nascsa.org/cdc-provisional-data-shows-dramatic-drop-in-drug-overdose-deaths/ 2025-05-15T13:35:42+00:00 https://nascsa.org/ohio-board-of-pharmacy-issues-joint-regulatory-statement-on-the-proliferation-of-retail-iv-therapy-clinics/ 2025-05-26T15:16:03+00:00 https://nascsa.org/report-highlights-alternative-funding-programs-illegally-sourcing-medications/ 2025-05-28T16:34:34+00:00 https://nascsa.org/legislation-moving-through-congress-substance-use-disorder-treatment/ 2025-06-12T13:25:05+00:00 https://nascsa.org/nominations-for-officers-and-board-members-sought/ 2025-06-14T13:39:17+00:00 https://nascsa.org/overdose-deaths-drop-more-than-25-in-2024/ 2025-06-19T11:36:09+00:00 https://nascsa.org/xylazine-more-commonly-identified-in-fentanyl-powders-according-to-dea/ 2025-06-19T11:37:48+00:00 https://nascsa.org/puerto-rico-ends-special-authorization-requirement-for-virtual-entities/ 2025-07-10T13:51:34+00:00 https://nascsa.org/nascsa-pmp-administrators-assist-dea-by-providing-data-to-help-establish-aggregate-production-quotas/ 2025-07-11T18:09:27+00:00 https://nascsa.org/cooper-davis-and-devin-norring-act-reintroduced-in-congress/ 2025-07-20T12:20:35+00:00 https://nascsa.org/senate-confirmation-of-dea-administrator-terrance-cole-advances/ 2025-07-22T11:30:57+00:00 https://nascsa.org/status-of-print-services-for-dea-registrants-restored-july-24-2025/ 2025-07-24T14:32:14+00:00 https://nascsa.org/dea-posts-leadership-listing/ 2025-07-28T12:14:47+00:00 https://nascsa.org/breaking-news-2024-national-survey-on-drug-use-and-health-released/ 2025-07-28T13:40:35+00:00 https://nascsa.org/fda-takes-aim-to-restrict-7-oh-opioid-products/ 2025-07-29T16:54:01+00:00 https://nascsa.org/fda-requires-major-changes-to-opioid-pain-medication-labeling-to-emphasize-risks/ 2025-08-03T14:20:22+00:00 https://nascsa.org/%e2%9d%97important-conference-hotel-information-%e2%9d%97/ 2025-08-18T12:03:16+00:00 https://nascsa.org/rocky-mountain-poison-drug-safety-rmpds-has-released-its-first-ever-comprehensive-data-report-from-the-national-survey-investigating-hallucinogenic-trends-nsiht/ 2025-08-28T16:04:14+00:00 https://nascsa.org/fy25-harold-rogers-prescription-drug-monitoring-program-funding-opportunity-announced/ 2025-09-18T13:04:50+00:00 https://nascsa.org/hhs-provides-more-than-1-5-billion-in-state-and-tribal-opioid-response-grants/ 2025-09-23T12:07:24+00:00 https://nascsa.org/californias-novel-approach-to-controlled-substance-inventory-and-loss-reporting/ 2025-09-25T11:46:40+00:00 https://nascsa.org/available-webinar-asap-through-the-years-a-journey-to-version-5-0/ 2025-09-25T12:34:59+00:00 https://nascsa.org/save-the-dates-annual-conference-dates-2026-2028/ 2025-10-16T12:58:37+00:00 https://nascsa.org/dea-to-host-drug-take-back-day-oct-25/ 2025-10-23T21:06:49+00:00 https://nascsa.org/free-continuing-education-for-pharmacists-technicians-on-improving-prescription-monitoring-program-pmp-data/ 2025-11-10T16:32:32+00:00 https://nascsa.org/new-survey-finds-two-thirds-of-americans-view-online-medicine-purchases-as-risky-up-22-points-since-2023/ 2025-11-14T13:03:04+00:00 https://nascsa.org/dea-to-host-webinar-covering-combat-methamphetamine-epidemic-act/ 2025-11-25T20:57:55+00:00 https://nascsa.org/dea-schedule-i-and-ii-controlled-substances-and-assessment-of-annual-needs-for-the-list-i-chemicals-ephedrine-pseudoephedrine-and-phenylpropanolamine-for-2026/ 2025-11-30T14:51:31+00:00 https://nascsa.org/dea-releases-fourth-temporary-extension-of-covid-19-telemedicine-flexibilities/ 2025-12-08T21:29:45+00:00 https://nascsa.org/kyle-zebley-to-lead-the-american-telemedicine-association/ 2025-12-09T12:30:45+00:00 https://nascsa.org/justice-department-seizes-unlawful-7-oh-opioid-products-at-three-warehouses/ 2025-12-09T15:22:02+00:00 https://nascsa.org/president-trump-signs-executive-order-increasing-medical-marijuana-and-cannabidiol-research/ 2025-12-19T12:59:37+00:00 https://nascsa.org/dea-extends-telemedicine-flexibilities-to-ensure-continued-access-to-care/ 2026-01-02T13:34:07+00:00 https://nascsa.org/compass-pathways-announces-fda-acceptance-of-ind-application-for-ptsd/ 2026-01-08T14:42:10+00:00 https://nascsa.org/sara-carter-confirmed-as-drug-czar/ 2026-01-08T14:51:53+00:00 https://nascsa.org/important-notice-updates-on-our-communication-methods/ 2026-01-17T14:06:57+00:00 https://nascsa.org/new-dea-rules-on-emergency-medical-services/ 2026-03-09T15:06:00+00:00 https://nascsa.org/dea-emergency-schedules-bromazolam/ 2026-03-23T14:44:45+00:00 https://nascsa.org/office-of-diversion-control-division-that-applications-will-be-offline-april-10-15/ 2026-04-09T19:14:18+00:00 https://nascsa.org/cdc-issues-health-advisory-on-medetomidine/ 2026-04-13T15:09:48+00:00 https://nascsa.org/president-trump-signs-executive-order-accelerating-medical-treatment-for-serious-mental-health/ 2026-04-19T11:33:52+00:00 https://nascsa.org/justice-department-places-fda-approved-marijuana-products-and-products-containing-marijuana-subject-to-a-qualifying-state-issued-license-in-schedule-iii/ 2026-04-23T14:15:03+00:00 https://nascsa.org/the-office-of-national-drug-control-policy-today-released-the-2026-national-drug-control-strategy/ 2026-05-10T13:41:10+00:00 https://nascsa.org/dea-to-hold-marijuana-rescheduling-hearing/ 2026-05-31T11:54:02+00:00 https://nascsa.org/the-department-of-veterans-affairs-va-proposes-to-amend-its-regulation-that-governs-disclosure-of-information-to-and-querying-of-state-prescription-drug-monitoring-programs-pdmps/ 2026-06-05T08:27:18+00:00 https://nascsa.org/dea-to-temporarily-schedule-7-oh-and-related-substances-to-protect-public-safety/ 2026-07-02T12:30:37+00:00 https://nascsa.org/on-april-23-2026-the-us-department-of-justice-released-an-update-to-the-scheduling-of-fda-approved-marijuana-products-and-products-containing-marijuana-to-schedule-iii-with-federal-controls/ 2026-07-11T01:34:00+00:00 https://nascsa.org/fda-proposes-rule-to-modernize-drug-manufacturing-registration/ 2026-07-11T14:29:58+00:00 https://nascsa.org/training-available-controlled-drug-prescribing-essential-aspects-of-investigation/ 2026-07-24T11:56:58+00:00 https://nascsa.org/samhsa-releases-annual-national-survey-on-drug-use-and-health/ 2026-07-28T11:52:19+00:00